INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/21/2026
Back to search
Official data from USPTO
OURLOOP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OURLOOP
ST13
US500000079198074Class
5, 9, 10, 41, 42, 44
Filing
79198074
Registration
5537615
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
62
Latest update
05/22/2026
Trademark type
Word
Nice classes
5, 9, 10, 41, 42, 44
Filing date
07/06/2016
Registration date
08/14/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/28/2025
Last transaction
05/22/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DK
Examiner
HENRY, NAKIA D
Law office
O20
Current location
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
Holders and representatives
Holders
M. A. (pessoa física)
H. Lundbeck A/S
Representatives
Claudia A. Smith WHITE & CASE LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorderstrokedepressioncognitive impairmentmood disorderspsychosisanxietyepilepsysclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderschizophreniabipolar disorder and diseaseADHDcancerpainalcoholism and dependency; diagnostic preparationssubstancesreagents and agents for medical purposes; pharmaceuticals for treatment of cognitive disorders
Class 9
Downloadable electronic publications in the nature of booksreportsbrochuresbookletsleafletspatient information leafletsmagazinesjournalsteaching and educational material in the field of clinicalmedicalpharmaceutical or clinical or medical diagnostic research and developmentclinical testsclinical or medical diagnosticmedicinepharmaceuticalsmedical disordersmedical diseasesclinical or medical treatment and prevention; application software for mobile devices for clinical or medical diagnostic purposes relating to mental or behavioral health; downloadable electronic publications in the nature of brochuresbooksmagazines related to assessment of cognitive functions; applications software for mobile devices for assessment of cognitive functions; downloadable software for assessment of cognitive functions; software application for measuring psychical and mental health; software used as an installation tool for software applications to retrieve data which is sent automatically
Class 10
Surgical and medical apparatus and instruments; diagnostic apparatus and instruments for medical purposes for monitoring patient behavior and medication compliance; integrated medical systems containing medical instruments and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for informationguidance and control of medicines
Class 41
Education in the nature classesseminarsworkshops in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; providing of training in the form of coursesseminarsworkshops in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; arranging and conducting seminarsconferencessymposiumsworkshops and courses in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; educational services in the nature of classesseminarsworkshopstraining services in the field of research and developmentscienceclinical testsdiagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention related to assessment of cognitive functions; providing the aforementioned services electronicallyon-linevia Internet or other electronic media; arranging and conducting expert in person educational forums in the field of clinicalmedicalpharmaceutical and medical diagnostic research and development; on-line training programs in the form of coursesseminarsworkshops in the field of research and developmentscienceclinical testsdiagnostic medicinepharmaceuticalswith regard to disordersdiseasestreatment and prevention related to assessment of cognitive functions; providing on-linenon-downloadable publicationsbooksreportsbrochuresbookletspatient information leafletsmagazinesjournalsteaching and educational material in the field of research and developmentscienceclinical testsdiagnostic medicinepharmaceuticals with regard to disordersdiseasestreatment and prevention related to assessment of cognitive functions
Class 42
Pharmaceutical research and development; scientific and technological servicesresearch in the field of medical disordersmedical diseases and medical treatment; scientific and technological servicesresearch in the field of the central nervous system and related disordersdiseases and pharmaceuticals related thereto; medical research and tests in the field of assessment of cognitive functions for mental or behavioral ill health; clinical research and tests in the field of the assessment of cognitive functions; providing online non-downloadable screening software for assessment of cognitive functions
Class 44
Medical and healthcare servicesproviding medical clinics providing assessment of cognitive functions and therapeutic servicesthe treatment of cognitive disorders and diseases; medical services in the field of psychiatry and psychology and diagnosis and treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders; providing medical and medicinal information in the field of diagnosticspharmaceuticalsdisordersdiseasestreatment and prevention; providing on-line medical data and analyses designed to provide patients with customized informationincluding information regarding medical dosediagnosistherapeutic issues; remote monitoring of data relating to patients health and diagnostics all offered via an Internet portal or an interactive platform
Publications
History of USPTO decisions and trademark events.
62 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/02/2026
INPC
INVALIDATION PROCESSED
05/02/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/28/2025
C71T
CANCELLED SECTION 71
02/28/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/14/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2018
FIMP
FINAL DISPOSITION PROCESSED
12/04/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/14/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/14/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/29/2018
PUBO
PUBLISHED FOR OPPOSITION
05/29/2018
GPNX
NOTIFICATION PROCESSED BY IB
05/25/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/16/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/16/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/09/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/09/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/20/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2018
GNRT
NON-FINAL ACTION E-MAILED
02/13/2018
CNRT
NON-FINAL ACTION WRITTEN
02/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/12/2018
GNRT
NON-FINAL ACTION E-MAILED
02/12/2018
CNRT
NON-FINAL ACTION WRITTEN
02/12/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/12/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/24/2017
GNRT
NON-FINAL ACTION E-MAILED
08/24/2017
CNRT
NON-FINAL ACTION WRITTEN
08/24/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/21/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/24/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/24/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/24/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/24/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/24/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2017
ALIE
ASSIGNED TO LIE
07/07/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2017
RFNT
REFUSAL PROCESSED BY IB
04/08/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/30/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/30/2016
RFRR
REFUSAL PROCESSED BY MPU
12/30/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/27/2016
CNRT
NON-FINAL ACTION WRITTEN
12/26/2016
MAFR
APPLICATION FILING RECEIPT MAILED
12/23/2016
DOCK
ASSIGNED TO EXAMINER
12/19/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/19/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/15/2016
Continuous trademark protection
Get notified about every new filing that threatens OURLOOP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.